Skip to main content

Outcomes After Transcatheter Mitral Valve Replacement According to Regurgitation Etiology.

The Annals of thoracic surgery

Authors: Nils Perrin, Walid Ben Ali, Sebastian Ludwig, Alison Duncan, Jessica Weimann, Georg Nickenig, Tetsu Tanaka, Augustin Coisne, Andre Vincentelli, Raj Makkar, John G Webb, Mariama Akodad, David W M Muller, Paul Jansz, Fabien Praz, David Reineke, Mirjam G Wild, Jörg Hausleiter, Sachin S Goel, Paolo Denti, Omar Chehab, Gry Dahle, Stephan Baldus, Hendrik Ruge, Tsuyoshi Kaneko, Julien Ternacle, Nicolas Dumonteil, Ralph Stephan von Bardeleben, Michele Flagiello, Thomas Walther, Maurizio Taramasso, Lars Søndergaard, Sabine Bleiziffer, Neil Fam, Joerg Kempfert, Juan F Granada, Gilbert H L Tang, Lenard Conradi, Thomas Modine

BACKGROUND: Whether transcatheter mitral valve replacement (TMVR) devices perform similarly with respect to the underlying mitral regurgitation (MR) etiology remains unelucidated yet. The aim of the present analysis was to assess outcomes of TMVR according to the MR underlying etiology among the CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry (CHOICE-MI) registry.

METHODS: Out of 746 patients, 229 (30.7%) patients underwent TMVR. The study population was subdivided according to primary, secondary or mixed MR. Patients with mitral annular calcification were excluded. The primary study endpoint was a composite endpoint of all-cause mortality or hospitalisation for heart failure at 1 year. Secondary study endpoints included all-cause and cardiovascular mortality at 1 year, New York Heart Association functional class and residual MR, both at discharge and 1 year.

RESULTS: The predominant MR etiology was secondary MR (58.4%), followed by primary MR (28.7%), and mixed MR (12.9%). Technical success was similar according to MR etiology as was procedural mortality. Discharge echocardiography revealed residual MR 2+ in 11.3%, 3.7%, and 5.3% of patients with primary, secondary, and mixed MR, respectively (P=0.1). MR elimination was similar in all groups up to the 1-year follow-up. There was no difference in terms of primary combined outcome occurrence according to MR etiology. One-year all-cause mortality was reported in 28.8%, 24.2% and 32.1% of the patients with primary, secondary and mixed MR (P=0.07), respectively.

CONCLUSIONS: In our study, we did not find differences in short- and 1-year outcomes after TMVR according to MR etiology.

Copyright © 2023. Published by Elsevier Inc.

PMID: 37717882

Participating cluster members